Patent details

EP1478394 Title: Stabilized TNFR-Fc composition comprising arginine

Basic Information

Publication number:
EP1478394
PCT Application Number:
PCT/US/2003/006222
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP037162443
PCT Publication Number:
WO/2003/072060
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Stabilized TNFR-Fc composition comprising arginine
French Title of Invention:
Composition stabilisée comprenant TNFR-Fc et arginine
German Title of Invention:
Stabilisierte TNFR-Fc Formulierung mit Arginin
SPC Number:

Dates

Filing date:
27/02/2003
Grant date:
30/07/2008
EP Publication Date:
30/07/2008
PCT Publication Date:
04/09/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/11/2004
EP B1 Publication Date:
30/07/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
27/02/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/02/2003
 
 

Name:
IMMUNEX CORPORATION
Address:
One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Agent

Name:
KIRKPATRICK SA / NV
From:
16/07/2008
Address:
AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)
To:

Inventor

1

Name:
REMMELE Richard, L., Jr.
Address:
United States (US)

2

Name:
GOMBOTZ Wayne, R.
Address:
United States (US)

Priority

Priority Number:
360257 P
Priority Date:
27/02/2002
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/395;

Publication

Bulletin

Bulletin Heading:
VB2
Bulletin edition number:
2019/03
Publication date:
22/02/2019
Description:
Section J : Applications for patents or supplementary protection certificates having been restored (art. 40 of the law) Patents or supplementary protection certificates having been restored (art. 70 of the law)

European Patent Bulletin

Issue number:
201730
Publication date:
26/07/2017
Description:
Opposition rejected; Patent maintained as granted

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
19/01/2022
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages